Literature DB >> 9472685

Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix.

N Jacobs1, S L Giannini, J Doyen, A Baptista, M Moutschen, J Boniver, P Delvenne.   

Abstract

It has been postulated that an impaired immune response may contribute to the progression of human papillomavirus (HPV)-associated preneoplastic lesions. Based on this hypothesis, we evaluated the cytokine production in the blood of patients with squamous intraepithelial lesions (SIL) of the uterine cervix. The levels of type-1 (interferon-gamma (IFN-gamma) and IL-12) and type-2(IL-4 and IL-10) cytokines were measured in whole blood culture supernatants of patients with low- and high-grade SIL and control women. There was no difference in IL-4 and IFN-gamma levels between patients with SIL and the control group. In contrast, the ratio of IL-12/IL-10 levels was significantly lower in patients with SIL compared with the control group. A lower IL-12/IL-10 ratio in women with SIL was also observed when peripheral blood mononuclear cell (PBMC) culture supernatants and plasma samples were analysed. In patients, neither the lower expression of the CD3epsilon chain nor the higher frequency of HLA-DRB1*1501 expression could be correlated with abnormal cytokine production. These results suggest that a part of the cytokine network, namely IL-10 and IL-12, is perturbed in patients with SIL. A better knowledge of the role of these cytokines in regulating the growth of HPV-associated SIL might have practical implications for the development of vaccines or immunomodulatory strategies in the treatment of cervical cancers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472685      PMCID: PMC1904851          DOI: 10.1046/j.1365-2249.1998.00437.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Evidence for a differential avidity model of T cell selection in the thymus.

Authors:  P G Ashton-Rickardt; A Bandeira; J R Delaney; L Van Kaer; H P Pircher; R M Zinkernagel; S Tonegawa
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

2.  Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women.

Authors:  L Gregoire; W D Lawrence; D Kukuruga; A B Eisenbrey; W D Lancaster
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

3.  HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.

Authors:  R J Apple; H A Erlich; W Klitz; M M Manos; T M Becker; C M Wheeler
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

4.  An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.

Authors:  J S Orange; C A Biron
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

Review 5.  Immunology of the human papilloma virus in relation to cancer.

Authors:  T C Wu
Journal:  Curr Opin Immunol       Date:  1994-10       Impact factor: 7.486

6.  Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions.

Authors:  K U Petry; D Scheffel; U Bode; T Gabrysiak; H Köchel; E Kupsch; M Glaubitz; S Niesert; H Kühnle; I Schedel
Journal:  Int J Cancer       Date:  1994-06-15       Impact factor: 7.396

7.  Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma.

Authors:  E Tartour; A Gey; X Sastre-Garau; C Pannetier; V Mosseri; P Kourilsky; W H Fridman
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

8.  Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.

Authors:  U Elsässer-Beile; S von Kleist; W Sauther; H Gallati; J S Mönting
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

9.  Impaired interleukin 12 production in human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; A D'Andrea; X Ma; R R MacGregor; J Sennelier; G Trinchieri
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Expression of interleukin 10 in human melanoma.

Authors:  S Krüger-Krasagakes; K Krasagakis; C Garbe; E Schmitt; C Hüls; T Blankenstein; T Diamantstein
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

View more
  13 in total

Review 1.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

2.  A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.

Authors:  A G Bais; I Beckmann; J Lindemans; P C Ewing; C J L M Meijer; P J F Snijders; T J M Helmerhorst
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

3.  Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression.

Authors:  S L Giannini; W Al-Saleh; H Piron; N Jacobs; J Doyen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

4.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.

Authors:  Aline Bolpetti; João S Silva; Luisa L Villa; Ana Paula Lepique
Journal:  BMC Immunol       Date:  2010-06-07       Impact factor: 3.615

5.  Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Authors:  Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Denise A Galloway; Janet R Daling; Mari Malkki; Effie W Petersdorf; Stephen M Schwartz
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

6.  Production of interferons and change of the lymphocyte subpopulation phenotype in peripheral blood at cervical papillomavirus infection.

Authors:  L Lazarenko; M Spivak; V Lakatosh; L Kryvokhatska; O Mikhailenko; A Rudenko; L Tkáciková; I Mikula
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

Review 7.  The paradox of IL-10-mediated modulation in cervical cancer.

Authors:  Yan Wang; Xiao-Hong Liu; Yue-Hong Li; Ou Li
Journal:  Biomed Rep       Date:  2013-02-26

Review 8.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

9.  Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

Authors:  S Della Bella; M Gennaro; M Vaccari; C Ferraris; S Nicola; A Riva; M Clerici; M Greco; M L Villa
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

10.  Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.

Authors:  Aagje G Bais; Ilse Beckmann; Patricia C Ewing; Marinus J C Eijkemans; Chris J L M Meijer; Peter J F Snijders; Theo J M Helmerhorst
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.